Literature DB >> 12855110

Effect of polyethyleneglycol (PEG) chain on cell uptake of PEG-modified liposomes.

Yasuyuki Sadzuka1, Kaori Kishi, Sadao Hirota, Takashi Sonobe.   

Abstract

The liposomalization and polyethyleneglycol (PEG) modification of antitumor agents prolongs their circulation in the blood and increases their accumulation in the tumor. It is expected that modification of the liposome surface with PEG-Lipid will prevent connection of liposome and tumor cell, so we examined the effect of PEG chain length and anchor length on liposome uptake into the tumor cell. It was obvious that modification of the liposome surface with PEG-Lipid did not prevent liposome uptake into tumor cells, but rather, promoted it. It was suggested that the increase in liposome uptake into the tumor cell was induced by modification of PEG-lipids with apparent stability. In other words, PEG 2,000-DPG, which had a high rate of residual PEG-Lipid on liposomal membrane depending on the re-uptake to liposomal membrane, met to this requirement.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12855110     DOI: 10.1081/lpr-120020318

Source DB:  PubMed          Journal:  J Liposome Res        ISSN: 0898-2104            Impact factor:   3.648


  8 in total

1.  Preparation, Characterization, and In Vitro Pharmacodynamics and Pharmacokinetics Evaluation of PEGylated Urolithin A Liposomes.

Authors:  Shengfu Yi; Cong Zhang; Junjie Hu; Yan Meng; Liang Chen; Huifan Yu; Shan Li; Guihong Wang; Guohua Zheng; Zhenpeng Qiu
Journal:  AAPS PharmSciTech       Date:  2021-01-06       Impact factor: 3.246

2.  Fluorescence microscopy colocalization of lipid-nucleic acid nanoparticles with wildtype and mutant Rab5-GFP: A platform for investigating early endosomal events.

Authors:  Ramsey N Majzoub; Chia-Ling Chan; Kai K Ewert; Bruno F B Silva; Keng S Liang; Cyrus R Safinya
Journal:  Biochim Biophys Acta       Date:  2015-03-06

3.  Cellular delivery of PEGylated PLGA nanoparticles.

Authors:  Sarala Pamujula; Sidhartha Hazari; Gevoni Bolden; Richard A Graves; Dakshinamurthy Devanga Chinta; Srikanta Dash; Vimal Kishore; Tarun K Mandal
Journal:  J Pharm Pharmacol       Date:  2011-11-24       Impact factor: 3.765

4.  Stearylamine Liposomal Delivery of Monensin in Combination with Free Artemisinin Eliminates Blood Stages of Plasmodium falciparum in Culture and P. berghei Infection in Murine Malaria.

Authors:  Vinoth Rajendran; Shilpa Rohra; Mohsin Raza; Gulam Mustafa Hasan; Suparna Dutt; Prahlad C Ghosh
Journal:  Antimicrob Agents Chemother       Date:  2015-12-14       Impact factor: 5.191

5.  Uptake and transfection efficiency of PEGylated cationic liposome-DNA complexes with and without RGD-tagging.

Authors:  Ramsey N Majzoub; Chia-Ling Chan; Kai K Ewert; Bruno F B Silva; Keng S Liang; Erica L Jacovetty; Bridget Carragher; Clinton S Potter; Cyrus R Safinya
Journal:  Biomaterials       Date:  2014-03-21       Impact factor: 12.479

6.  Efficacy of Liposomal Monensin on the Enhancement of the Antitumour Activity of Liposomal Ricin in Human Epidermoid Carcinoma (KB) Cells.

Authors:  N Tyagi; S S Rathore; P C Ghosh
Journal:  Indian J Pharm Sci       Date:  2013-01       Impact factor: 0.975

7.  Oleanolic acid liposomes with polyethylene glycol modification: promising antitumor drug delivery.

Authors:  Dawei Gao; Shengnan Tang; Qi Tong
Journal:  Int J Nanomedicine       Date:  2012-07-06

8.  Bispecific antibodies (anti-mPEG/anti-HER2) for active tumor targeting of docetaxel (DTX)-loaded mPEGylated nanocarriers to enhance the chemotherapeutic efficacy of HER2-overexpressing tumors.

Authors:  Chia-Yu Su; Michael Chen; Ling-Chun Chen; Yuan-Soon Ho; Hsiu-O Ho; Shyr-Yi Lin; Kuo-Hsiang Chuang; Ming-Thau Sheu
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.